LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China flag China · Delayed Price · Currency is CNY
14.96
+0.05 (0.34%)
At close: Feb 27, 2026

SHA:603883 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
22,05122,21322,28820,05515,57913,867
Other Revenue
144.48144.48149.26120.29117.1199.9
22,19622,35822,43720,17615,69613,967
Revenue Growth (YoY)
-1.91%-0.36%11.21%28.54%12.38%19.75%
Cost of Revenue
15,05314,94615,15713,75110,6599,506
Gross Profit
7,1437,4127,2806,4255,0374,461
Selling, General & Admin
6,0876,2055,7535,0053,9903,483
Research & Development
65.052.012.512.23-0.15
Other Operating Expenses
57.7833.6846.2138.5114.9543.66
Operating Expenses
6,2156,2475,8115,0534,0103,536
Operating Income
927.311,1651,4691,3711,027924.58
Interest Expense
-140.41-178.25-185.6-232.14-192.13-58.49
Interest & Investment Income
21.9422.8393.8751.3537.1420.77
Currency Exchange Gain (Loss)
-1.25-1.25-5.22-16.914.8-
Other Non Operating Income (Expenses)
-8.11-13.65-14.61-13.4-14.44-27.93
EBT Excluding Unusual Items
799.48994.51,3571,160861.9858.93
Impairment of Goodwill
-107.54-107.54----
Gain (Loss) on Sale of Investments
1.5--1.55.7710.47-
Gain (Loss) on Sale of Assets
-5.2-4.535.511.444.66-1.43
Asset Writedown
-0.7-----
Other Unusual Items
76.5533.5446.6940.2184.9599.37
Pretax Income
764.09915.971,4081,208961.99956.86
Income Tax Expense
186.33230.85284.27231.37175.26192.38
Earnings From Continuing Operations
577.76685.121,124976.24786.73764.48
Minority Interest in Earnings
-160.2-166.05-194.54-191.28-117.49-143.39
Net Income
417.56519.06929.02784.96669.24621.09
Net Income to Common
417.56519.06929.02784.96669.24621.09
Net Income Growth
-50.44%-44.13%18.35%17.29%7.75%22.09%
Shares Outstanding (Basic)
760763755750707682
Shares Outstanding (Diluted)
760763755750707691
Shares Change (YoY)
0.97%1.06%0.67%6.08%2.42%1.21%
EPS (Basic)
0.550.681.231.050.950.91
EPS (Diluted)
0.550.681.231.050.950.90
EPS Growth
-50.92%-44.71%17.57%10.57%5.20%20.63%
Free Cash Flow
2,5261,5192,1092,0061,8201,053
Free Cash Flow Per Share
3.321.992.792.672.571.52
Dividend Per Share
0.2200.4110.5080.3850.2960.207
Dividend Growth
-73.76%-19.11%32.01%30.02%42.83%16.68%
Gross Margin
32.18%33.15%32.45%31.84%32.09%31.94%
Operating Margin
4.18%5.21%6.55%6.80%6.54%6.62%
Profit Margin
1.88%2.32%4.14%3.89%4.26%4.45%
Free Cash Flow Margin
11.38%6.79%9.40%9.94%11.59%7.54%
EBITDA
1,0971,3451,6621,5331,1621,037
EBITDA Margin
4.94%6.01%7.41%7.60%7.41%7.42%
D&A For EBITDA
169.46179.84193.69161.87135.67112.02
EBIT
927.311,1651,4691,3711,027924.58
EBIT Margin
4.18%5.21%6.55%6.80%6.54%6.62%
Effective Tax Rate
24.39%25.20%20.19%19.16%18.22%20.11%
Revenue as Reported
22,19622,35822,43720,17615,69613,967
Advertising Expenses
-115.57117.9994.5109.84103.68
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.